574(top 100%)
papers
45.0K(top 0.1%)
citations
109(top 100%)
h-index
204(top 100%)
g-index
631
all documents
51.0K
doc citations
3.6K
citing journals
100
times ranked

Publications

602 papers • 51,036 citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Understanding the Role of Oxidative Stress, Neuroinflammation and Abnormal Myelination in Excessive Aggression Associated with Depression: Recent Input from Mechanistic Studies4.520Citations (PDF)
2Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The <scp>ENIGMA</scp> adventure
Human Brain Mapping, 2022, 43, 37-55
3.867Citations (PDF)
3Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years
Human Brain Mapping, 2022, 43, 431-451
3.8144Citations (PDF)
4Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years
Human Brain Mapping, 2022, 43, 452-469
3.880Citations (PDF)
5Chronic mild stress paradigm as a rat model of depression: facts, artifacts, and future perspectives
Psychopharmacology, 2022, 239, 663-693
3.065Citations (PDF)
6The Combined Effects of Amyloidosis and Serotonin Deficiency by Tryptophan Hydroxylase-2 Knockout Impacts Viability of the APP/PS1 Mouse Model of Alzheimer’s Disease
Journal of Alzheimer's Disease, 2022, 85, 1283-1300
2.75Citations (PDF)
7Hippocampal Over-Expression of Cyclooxygenase-2 (COX-2) Is Associated with Susceptibility to Stress-Induced Anhedonia in Mice4.515Citations (PDF)
8Predation Stress Causes Excessive Aggression in Female Mice with Partial Genetic Inactivation of Tryptophan Hydroxylase-2: Evidence for Altered Myelination-Related Processes
Cells, 2022, 11, 1036
4.86Citations (PDF)
9Exploring the Contribution to ADHD of Genes Involved in Mendelian Disorders Presenting with Hyperactivity and/or Inattention
Genes, 2022, 13, 93
2.74Citations (PDF)
10Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic and molecular genetic levels of analysis
Nature Genetics, 2022, 54, 548-559
16.3133Citations (PDF)
11The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects4.152Citations (PDF)
12Altered behaviour, dopamine and norepinephrine regulation in stressed mice heterozygous in TPH2 gene4.112Citations (PDF)
13Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders
JAMA Psychiatry, 2021, 78, 47
14.1143Citations (PDF)
14REVERSE phenotyping—Can the phenotype <i>following constitutive Tph2 gene inactivation in mice</i> be transferred to children and adolescents with and without adhd?
Brain and Behavior, 2021, 11,
2.54Citations (PDF)
15Serotonin transporter genotype modulates resting state and predator stress-induced amygdala perfusion in mice in a sex-dependent manner
PLoS ONE, 2021, 16, e0247311
2.53Citations (PDF)
16Serotonin-specific neurons differentiated from human iPSCs form distinct subtypes with synaptic protein assembly
Journal of Neural Transmission, 2021, 128, 225-241
3.610Citations (PDF)
17No links between genetic variation and developing theory of mind: A preregistered replication attempt of candidate gene studies3.47Citations (PDF)
18Serotonin deficiency induced after brain maturation rescues consequences of early life adversity
Scientific Reports, 2021, 11,
3.75Citations (PDF)
19Analysis of structural brain asymmetries in attention‐deficit/hyperactivity disorder in 39 datasets7.048Citations (PDF)
20Dorsal raphe serotonin neurotransmission is required for the expression of nursing behavior and for pup survival
Scientific Reports, 2021, 11,
3.77Citations (PDF)
21Generation of induced pluripotent stem cell (iPSC) lines carrying a heterozygous (UKWMPi002-A-1) and null mutant knockout (UKWMPi002-A-2) of Cadherin 13 associated with neurodevelopmental disorders using CRISPR/Cas9
Stem Cell Research, 2021, 51, 102169
0.63Citations (PDF)
22Increased Oxidative Stress in the Prefrontal Cortex as a Shared Feature of Depressive- and PTSD-Like Syndromes: Effects of a Standardized Herbal Antioxidant4.424Citations (PDF)
23Cadherin-13 is a critical regulator of GABAergic modulation in human stem-cell-derived neuronal networks
Molecular Psychiatry, 2021, 27, 1-18
8.376Citations (PDF)
245-HTT Deficiency in Male Mice Affects Healing and Behavior after Myocardial Infarction2.65Citations (PDF)
25The continued need for animals to advance brain research
Neuron, 2021, 109, 2374-2379
12.843Citations (PDF)
26A Common CDH13 Variant Is Associated with Low Agreeableness and Neural Responses to Working Memory Tasks in ADHD
Genes, 2021, 12, 1356
2.76Citations (PDF)
27Haploinsufficiency of the Attention-Deficit/Hyperactivity Disorder Risk Gene St3gal3 in Mice Causes Alterations in Cognition and Expression of Genes Involved in Myelination and Sialylation2.414Citations (PDF)
28Generation of multiple human iPSC lines from peripheral blood mononuclear cells of two SLC2A3 deletion and two SLC2A3 duplication carriers
Stem Cell Research, 2021, 56, 102526
0.60Citations (PDF)
29ASD-like behaviors, a dysregulated inflammatory response and decreased expression of PLP1 characterize mice deficient for sialyltransferase ST3GAL52.510Citations (PDF)
30Increased locomotor activity via regulation of GABAergic signalling in foxp2 mutant zebrafish—implications for neurodevelopmental disorders5.712Citations (PDF)
31Sex-Specific ADHD-like Behaviour, Altered Metabolic Functions, and Altered EEG Activity in Sialyltransferase ST3GAL5-Deficient Mice
Biomolecules, 2021, 11, 1759
4.45Citations (PDF)
32<i>KCNJ6</i> variants modulate reward‐related brain processes and impact executive functions in attention‐deficit/hyperactivity disorder1.89Citations (PDF)
33Prefrontal cortex inflammation and liver pathologies accompany cognitive and motor deficits following Western diet consumption in non-obese female mice
Life Sciences, 2020, 241, 117163
4.534Citations (PDF)
34Neuro‐Cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice5.124Citations (PDF)
35Molecular and behavioural abnormalities in the FUS‐tg mice mimic frontotemporal lobar degeneration: Effects of old and new anti‐inflammatory therapies4.111Citations (PDF)
36Transcriptome profiling in adult attention-deficit hyperactivity disorder0.99Citations (PDF)
37The genetic architecture of human brainstem structures and their involvement in common brain disorders14.124Citations (PDF)
38Effect of serotonin transporter genotype on carbon dioxide-induced fear-related behavior in mice
Journal of Psychopharmacology, 2020, 34, 1408-1417
5.80Citations (PDF)
39Stress-induced aggression in heterozygous TPH2 mutant mice is associated with alterations in serotonin turnover and expression of 5-HT6 and AMPA subunit 2A receptors
Journal of Affective Disorders, 2020, 272, 440-451
4.720Citations (PDF)
40Mental health dished up—the use of iPSC models in neuropsychiatric research
Journal of Neural Transmission, 2020, 127, 1547-1568
3.620Citations (PDF)
41Cellular effects and clinical implications of <i>SLC2A3</i> copy number variation
Journal of Cellular Physiology, 2020, 235, 9021-9036
4.232Citations (PDF)
42Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups
American Journal of Psychiatry, 2020, 177, 834-843
10.5135Citations (PDF)
43Metabolic, Molecular, and Behavioral Effects of Western Diet in Serotonin Transporter-Deficient Mice: Rescue by Heterozygosity?3.018Citations (PDF)
44DNA methylation in the 5-HTT regulatory region is associated with CO2-induced fear in panic disorder patients0.98Citations (PDF)
45Rhythm and blues: Influence of CLOCK T3111C on peripheral electrophysiological indicators of negative affective processing
Physiology and Behavior, 2020, 219, 112831
2.42Citations (PDF)
46Serotonin (5-HT) neuron-specific inactivation of Cadherin-13 impacts 5-HT system formation and cognitive function
Neuropharmacology, 2020, 168, 108018
4.514Citations (PDF)
47Delaying memory decline: different options and emerging solutions5.714Citations (PDF)
48Shared genetic background between children and adults with attention deficit/hyperactivity disorder
Neuropsychopharmacology, 2020, 45, 1617-1626
5.475Citations (PDF)
49Impulsivity and Venturesomeness in an Adult ADHD Sample: Relation to Personality, Comorbidity, and Polygenic Risk2.78Citations (PDF)
50Effects of maternal separation on serotonergic systems in the dorsal and median raphe nuclei of adult male Tph2-deficient mice
Behavioural Brain Research, 2019, 373, 112086
2.312Citations (PDF)
51Hypermethylation of the serotonin transporter gene promoter in panic disorder–Epigenetic imprint of comorbid depression?0.915Citations (PDF)
52Loss of Orai2-Mediated Capacitative Ca <sup>2+</sup> Entry Is Neuroprotective in Acute Ischemic Stroke
Stroke, 2019, 50, 3238-3245
6.234Citations (PDF)
53Transcript Analysis of Zebrafish GLUT3 Genes, slc2a3a and slc2a3b, Define Overlapping as Well as Distinct Expression Domains in the Zebrafish (Danio rerio) Central Nervous System3.56Citations (PDF)
54Common brain disorders are associated with heritable patterns of apparent aging of the brain
Nature Neuroscience, 2019, 22, 1617-1623
12.4331Citations (PDF)
55Fgf3 is crucial for the generation of monoaminergic cerebrospinal fluid contacting cells in zebrafish
Biology Open, 2019, ,
1.54Citations (PDF)
56Serotonin Deficiency Increases Context-Dependent Fear Learning Through Modulation of Hippocampal Activity3.024Citations (PDF)
57Identification of Cholecystokinin by Genome-Wide Profiling as Potential Mediator of Serotonin-Dependent Behavioral Effects of Maternal Separation in the Amygdala3.013Citations (PDF)
58Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples
American Journal of Psychiatry, 2019, 176, 531-542
10.5297Citations (PDF)
59Serotonin transporter gene hypermethylation – an epigenetic footprint of depressive symptomatology in panic disorder?0.90Citations (PDF)
60Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation
Neuropharmacology, 2019, 156, 107557
4.537Citations (PDF)
61Repeated methamphetamine treatment increases spine density in the nucleus accumbens of serotonin transporter knockout mice1.93Citations (PDF)
62Family-based association study on functional α-synuclein polymorphisms in attention-deficit/hyperactivity disorder2.69Citations (PDF)
63Brain serotonin deficiency affects female aggression3.725Citations (PDF)
64Cross-species models of attention-deficit/hyperactivity disorder and autism spectrum disorder
Psychiatric Genetics, 2019, 29, 1-17
1.423Citations (PDF)
65Editorial: Can dysregulated myelination be linked to <scp>ADHD</scp> pathogenesis and persistence?7.020Citations (PDF)
66The DNA methylome in panic disorder: a case-control and longitudinal psychotherapy-epigenetic study5.732Citations (PDF)
67Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders
Cell, 2019, 179, 1469-1482.e11
35.1856Citations (PDF)
68Early-life stress impairs developmental programming in Cadherin 13 (CDH13)-deficient mice4.114Citations (PDF)
69Improved cognition, mild anxiety-like behavior and decreased motor performance in pyridoxal phosphatase-deficient mice4.119Citations (PDF)
70The involvement of the canonical Wnt‐signaling receptor <i>LRP5</i> and <i>LRP6</i> gene variants with ADHD and sexual dimorphism: Association study and meta‐analysis1.819Citations (PDF)
71Relapse of drunk driving and association with traffic accidents, alcohol-related problems and biomarkers of impulsivity
Acta Neuropsychiatrica, 2019, 31, 84-92
2.310Citations (PDF)
72Cumulative Dopamine Genetic Score predicts behavioral and electrophysiological correlates of response inhibition via interactions with task demand2.07Citations (PDF)
73Generation of a human induced pluripotent stem cell (iPSC) line from a 51-year-old female with attention-deficit/hyperactivity disorder (ADHD) carrying a duplication of SLC2A3
Stem Cell Research, 2018, 28, 136-140
0.611Citations (PDF)
74Expression of the ADHD candidate gene Diras2 in the brain
Journal of Neural Transmission, 2018, 125, 913-923
3.66Citations (PDF)
75Insulin receptor in the brain: Mechanisms of activation and the role in the <scp>CNS</scp> pathology and treatment5.1143Citations (PDF)
76‘Shine bright like a diamond!’: is research on high‐functioning <scp>ADHD</scp> at last entering the mainstream?7.018Citations (PDF)
77A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder
Biological Psychiatry, 2018, 83, 1044-1053
1.7129Citations (PDF)
78Intellectual Investment, Dopaminergic Gene Variation, and Life Events: A Critical Examination1.62Citations (PDF)
79Functional analysis of a triplet deletion in the gene encoding the sodium glucose transporter 3, a potential risk factor for ADHD
PLoS ONE, 2018, 13, e0205109
2.55Citations (PDF)
80Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan0.9421Citations (PDF)
81In Memoriam2.02Citations (PDF)
82Family environment interacts with CRHR1 rs17689918 to predict mental health and behavioral outcomes4.111Citations (PDF)
83Genetic variation in serotonin function impacts on altruistic punishment in the ultimatum game: A longitudinal approach
Brain and Cognition, 2018, 125, 37-44
0.97Citations (PDF)
84Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium7.7278Citations (PDF)
85Analysis of shared heritability in common disorders of the brain
Science, 2018, 360,
38.21,055Citations (PDF)
86Differential anxiety-related behaviours and brain activation in Tph2-deficient female mice exposed to adverse early environment0.910Citations (PDF)
87Special Editorial: Open science and the Journal of Child Psychology &amp; Psychiatry – next steps?7.07Citations (PDF)
88Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
Nature Genetics, 2018, 51, 63-75
16.31,420Citations (PDF)
89Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing
Molecular Psychiatry, 2018, 25, 2047-2057
8.318Citations (PDF)
90<i><scp>SLC</scp>2A3</i> single‐nucleotide polymorphism and duplication influence cognitive processing and population‐specific risk for attention‐deficit/hyperactivity disorder7.027Citations (PDF)
91Zebrafish Models of Attention-Deficit/Hyperactivity Disorder (ADHD)
2017, , 145-169
1Citations (PDF)
92Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis
Lancet Psychiatry,the, 2017, 4, 310-319
9.0591Citations (PDF)
93T-cadherin promotes autophagy and survival in vascular smooth muscle cells through MEK1/2/Erk1/2 axis activation
Cellular Signalling, 2017, 35, 163-175
3.523Citations (PDF)
94Postnatal LPS Challenge Impacts Escape Learning and Expression of Plasticity Factors Mmp9 and Timp1 in Rats: Effects of Repeated Training
Neurotoxicity Research, 2017, 32, 175-186
3.013Citations (PDF)
95Effect of aging and Alzheimer's disease-like pathology on brain monoamines in mice
Neurochemistry International, 2017, 108, 238-245
3.629Citations (PDF)
96Rsk2 Knockout Affects Emotional Behavior in the IntelliCage
Behavior Genetics, 2017, 47, 434-448
1.812Citations (PDF)
97Genetically driven brain serotonin deficiency facilitates panic-like escape behavior in mice
Translational Psychiatry, 2017, 7, e1246-e1246
5.724Citations (PDF)
98Impact of varying social experiences during life history on behaviour, gene expression, and vasopressin receptor gene methylation in mice3.723Citations (PDF)
99Elucidating the functions of brain GSK3α: Possible synergy with GSK3β upregulation and reversal by antidepressant treatment in a mouse model of depressive-like behaviour
Behavioural Brain Research, 2017, 335, 122-127
2.325Citations (PDF)
100Increased functional coupling of 5-HT 1A autoreceptors to GIRK channels in Tph2 -/- mice0.99Citations (PDF)
101Thiamine and benfotiamine improve cognition and ameliorate GSK-3β-associated stress-induced behaviours in mice4.138Citations (PDF)
102Genetic Overlap Between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence From Genome-wide Association Study Meta-analysis
Biological Psychiatry, 2017, 82, 634-641
1.7101Citations (PDF)
103Cadherin-13 Deficiency Increases Dorsal Raphe 5-HT Neuron Density and Prefrontal Cortex Innervation in the Mouse Brain3.519Citations (PDF)
104Autism-Like Behaviours and Memory Deficits Result from a Western Diet in Mice
Neural Plasticity, 2017, 2017, 1-14
3.327Citations (PDF)
105Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer’s-like disease in mice6.717Citations (PDF)
106OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB/ERK-MAPK signaling as a result of SPRED2 deficiency
Molecular Psychiatry, 2017, 23, 444-458
8.364Citations (PDF)
107Longitudinal analyses of the DNA methylome in deployed military servicemen identify susceptibility loci for post-traumatic stress disorder
Molecular Psychiatry, 2017, 23, 1145-1156
8.398Citations (PDF)
108Pro-neurogenic, Memory-Enhancing and Anti-stress Effects of DF302, a Novel Fluorine Gamma-Carboline Derivative with Multi-target Mechanism of Action
Molecular Neurobiology, 2017, 55, 335-349
3.823Citations (PDF)
109Cadherin 13: Human cis-Regulation and Selectively Altered Addiction Phenotypes and Cerebral Cortical Dopamine in Knockout Mice
Molecular Medicine, 2016, 22, 537-547
5.725Citations (PDF)
110Individual Differences in Behavioural Despair Predict Brain GSK-3beta Expression in Mice: The Power of a Modified Swim Test
Neural Plasticity, 2016, 2016, 1-17
3.318Citations (PDF)
111The Unexpected Effects of Beneficial and Adverse Social Experiences during Adolescence on Anxiety and Aggression and Their Modulation by Genotype2.516Citations (PDF)
112Brain-Derived Neurotrophic Factor (Val66Met) and Serotonin Transporter (5-HTTLPR) Polymorphisms Modulate Plasticity in Inhibitory Control Performance Over Time but Independent of Inhibitory Control Training2.610Citations (PDF)
113Hypermethylation of FOXP3 Promoter and Premature Aging of the Immune System in Female Patients with Panic Disorder?
PLoS ONE, 2016, 11, e0157930
2.514Citations (PDF)
114Serotonergic modulation of ‘waiting impulsivity’ is mediated by the impulsivity phenotype in humans
Translational Psychiatry, 2016, 6, e940-e940
5.715Citations (PDF)
115Ultrasound of alternating frequencies and variable emotional impact evokes depressive syndrome in mice and rats4.127Citations (PDF)
116Whole-Exome Sequencing Reveals Increased Burden of Rare Functional and Disruptive Variants in Candidate Risk Genes in Individuals With Persistent Attention-Deficit/Hyperactivity Disorder0.627Citations (PDF)
117BDNF val66met genotype shows distinct associations with the acoustic startle reflex and the cortisol stress response in young adults and children
Psychoneuroendocrinology, 2016, 66, 39-46
2.519Citations (PDF)
118Insulin receptor sensitizer, dicholine succinate, prevents both Toll-like receptor 4 (TLR4) upregulation and affective changes induced by a high-cholesterol diet in mice
Journal of Affective Disorders, 2016, 196, 109-116
4.721Citations (PDF)
119MAOA gene hypomethylation in panic disorder—reversibility of an epigenetic risk pattern by psychotherapy
Translational Psychiatry, 2016, 6, e773-e773
5.7145Citations (PDF)
120Developmental exposure to acetaminophen does not induce hyperactivity in zebrafish larvae
Journal of Neural Transmission, 2016, 123, 841-848
3.614Citations (PDF)
121Low-dose lipopolysaccharide (LPS) inhibits aggressive and augments depressive behaviours in a chronic mild stress model in mice9.293Citations (PDF)
122Functional Impact of An ADHD-Associated DIRAS2 Promoter Polymorphism
Neuropsychopharmacology, 2016, 41, 3025-3031
5.48Citations (PDF)
123CO2 exposure as translational cross-species experimental model for panic
Translational Psychiatry, 2016, 6, e885-e885
5.743Citations (PDF)
124Meta-analysis of the DRD5 VNTR in persistent ADHD0.95Citations (PDF)
125Genome‐wide analyses of aggressiveness in attention‐deficit hyperactivity disorder1.840Citations (PDF)
126Maturing insights into the genetic architecture of neurodevelopmental disorders – from common and rare variant interplay to precision psychiatry7.08Citations (PDF)
127Early citalopram treatment increases mortality due to left ventricular rupture in mice after myocardial infarction2.08Citations (PDF)
128Reducing central serotonin in adulthood promotes hippocampal neurogenesis3.745Citations (PDF)
129The role of ASTN2 variants in childhood and adult ADHD, comorbid disorders and associated personality traits
Journal of Neural Transmission, 2016, 123, 849-858
3.68Citations (PDF)
130Sex- and Subtype-Related Differences in the Comorbidity of Adult ADHDs3.030Citations (PDF)
131Sex- and Subtype-Related Differences of Personality Disorders (Axis II) and Personality Traits in Persistent ADHD
Journal of Attention Disorders, 2016, 20, 1056-1065
3.017Citations (PDF)
132Methylphenidate and emotional-motivational processing in attention-deficit/hyperactivity disorder
Journal of Neural Transmission, 2016, 123, 971-979
3.68Citations (PDF)
133Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex
Brain Imaging and Behavior, 2016, 11, 1497-1514
2.2130Citations (PDF)
134Partially Defective Store Operated Calcium Entry and Hem(ITAM) Signaling in Platelets of Serotonin Transporter Deficient Mice
PLoS ONE, 2016, 11, e0147664
2.524Citations (PDF)
135Behavioral Features of Mice Fed with a Cholesterol-Enriched Diet: Deficient Novelty Exploration and Unaltered Aggressive Behavior0.15Citations (PDF)
136On the role of <i>NOS1</i> ex1f‐VNTR in ADHD—allelic, subgroup, and meta‐analysis1.819Citations (PDF)
137Methylone-induced hyperthermia and lethal toxicity
Behavioural Pharmacology, 2015, 26, 345-352
3.816Citations (PDF)
138Dicholine succinate, the neuronal insulin sensitizer, normalizes behavior, REM sleep, hippocampal pGSK3 beta and mRNAs of NMDA receptor subunits in mouse models of depression2.515Citations (PDF)
139Benefits of adversity?! How life history affects the behavioral profile of mice varying in serotonin transporter genotype2.521Citations (PDF)
140Annual Research Review: The (epi)genetics of neurodevelopmental disorders in the era of whole‐genome sequencing – unveiling the dark matter7.048Citations (PDF)
141Further evidence for the association of the <i>NPSR1</i> gene A/T polymorphism (Asn<sup>107</sup>Ile) with impulsivity and hyperactivity5.822Citations (PDF)
142Deuterium content of water increases depression susceptibility: The potential role of a serotonin-related mechanism
Behavioural Brain Research, 2015, 277, 237-244
2.358Citations (PDF)
143Benefits of a “vulnerability gene”? A study in serotonin transporter knockout mice
Behavioural Brain Research, 2015, 283, 116-120
2.319Citations (PDF)
144Genomic structural variants are linked with intellectual disability
Journal of Neural Transmission, 2015, 122, 1289-1301
3.620Citations (PDF)
145Oxytocin Receptor Gene Methylation: Converging Multilevel Evidence for a Role in Social Anxiety
Neuropsychopharmacology, 2015, 40, 1528-1538
5.4154Citations (PDF)
146A preliminary study on methylphenidate-regulated gene expression in lymphoblastoid cells of ADHD patients3.912Citations (PDF)
147Tlr4 upregulation in the brain accompanies depression- and anxiety-like behaviors induced by a high-cholesterol diet4.357Citations (PDF)
148Interaction of brain 5-HT synthesis deficiency, chronic stress and sex differentially impact emotional behavior in Tph2 knockout mice
Psychopharmacology, 2015, 232, 2429-2441
3.077Citations (PDF)
149MicroRNA hsa‐miR‐4717‐5p regulates RGS2 and may be a risk factor for anxiety‐related traits1.822Citations (PDF)
150The brain acid–base homeostasis and serotonin: A perspective on the use of carbon dioxide as human and rodent experimental model of panic
Progress in Neurobiology, 2015, 129, 58-78
6.029Citations (PDF)
151Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment
Behavioural Pharmacology, 2015, 26, 167-179
3.811Citations (PDF)
152Cellular resilience: 5-HT neurons in Tph2−/− mice retain normal firing behavior despite the lack of brain 5-HT0.917Citations (PDF)
153Defeat stress in rodents: From behavior to molecules7.3181Citations (PDF)
154Neuropeptide S receptor gene variant and environment: contribution to alcohol use disorders and alcohol consumption
Addiction Biology, 2015, 20, 605-616
2.728Citations (PDF)
155Editorial: Attention‐deficit/hyperactivity disorder: a continuing challenge to researchers, practitioners and carers7.01Citations (PDF)
156Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition
Translational Psychiatry, 2015, 5, e655-e655
5.792Citations (PDF)
157P.7.a.001 Effect of cadherin-13 inactivation on hippocampal processes and hippocampus-related behavior: a mouse model for ADHD?0.90Citations (PDF)
158Multi-level biomarker analysis of nitric oxide synthase isoforms in bipolar disorder and adult ADHD5.829Citations (PDF)
159Lasting downregulation of the lipid peroxidation enzymes in the prefrontal cortex of mice susceptible to stress-induced anhedonia
Behavioural Brain Research, 2015, 276, 118-129
2.331Citations (PDF)
160Endotoxaemia resulting from decreased serotonin tranporter (5-HTT) function: A reciprocal risk factor for depression and insulin resistance?
Behavioural Brain Research, 2015, 276, 111-117
2.333Citations (PDF)
161Variability in the Effect of 5-HTTLPR on Depression in a Large European Population: The Role of Age, Symptom Profile, Type and Intensity of Life Stressors
PLoS ONE, 2015, 10, e0116316
2.529Citations (PDF)
162Experimental heart failure causes depression-like behavior together with differential regulation of inflammatory and structural genes in the brain2.540Citations (PDF)
163Prenatal stress-induced programming of genome-wide promoter DNA methylation in 5-HTT-deficient mice
Translational Psychiatry, 2014, 4, e473-e473
5.739Citations (PDF)
164Autonomic hypoactivity in boys with attention-deficit/hyperactivity disorder and the influence of methylphenidate3.928Citations (PDF)
165Interaction of the neuropeptide S receptor gene Asn107Ile variant and environment: contribution to affective and anxiety disorders, and suicidal behaviour2.042Citations (PDF)
166A functional <i>NPSR1</i> gene variant and environment shape personality and impulsive action: A longitudinal study5.835Citations (PDF)
167Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response2.0146Citations (PDF)
168Editorial: Illuminating the dark matter of developmental neuropsychiatric genetics – strategic focus for future research in child psychology and psychiatry7.07Citations (PDF)
169Variation in Key Genes of Serotonin and Norepinephrine Function Predicts Gamma-Band Activity during Goal-Directed Attention
Cerebral Cortex, 2014, 24, 1195-1205
2.918Citations (PDF)
170The epigenome and postnatal environmental influences in psychotic disorders2.930Citations (PDF)
171Internalizing and externalizing behavior in adult ADHD2.628Citations (PDF)
172Genetic variation associated with euphorigenic effects of <i>d</i> -amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder7.717Citations (PDF)
173The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: Further evidence and meta-analysis0.937Citations (PDF)
174Stratified medicine for mental disorders0.9154Citations (PDF)
175Epigenetically regulated microRNAs in Alzheimer's disease
Neurobiology of Aging, 2014, 35, 731-745
3.4101Citations (PDF)
176Developmental alterations in anxiety and cognitive behavior in serotonin transporter mutant mice
Psychopharmacology, 2014, 231, 4119-4133
3.019Citations (PDF)
177Imaging genetics in adult attention-deficit/hyperactivity disorder (ADHD): a way towards pathophysiological understanding?2.29Citations (PDF)
178Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems
Neuropharmacology, 2014, 76, 146-155
4.535Citations (PDF)
179Prenatal stress and subsequent exposure to chronic mild stress in rats; interdependent effects on emotional behavior and the serotonergic system0.9114Citations (PDF)
180Case–Control Genome-Wide Association Study of Persistent Attention-Deficit Hyperactivity Disorder Identifies FBXO33 as a Novel Susceptibility Gene for the Disorder
Neuropsychopharmacology, 2014, 40, 915-926
5.456Citations (PDF)
181Pharmacoepigenetics of depression: no major influence of MAO-A DNA methylation on treatment response3.645Citations (PDF)
182Hope for the Best or Prepare for the Worst? Towards a Spatial Cognitive Bias Test for Mice
PLoS ONE, 2014, 9, e105431
2.534Citations (PDF)
183A novel approach to probabilistic biomarker‐based classification using functional near‐infrared spectroscopy
Human Brain Mapping, 2013, 34, 1102-1114
3.824Citations (PDF)
184The tricks of the trait: Neural implementation of personality varies with genotype-dependent serotonin levels
NeuroImage, 2013, 81, 393-399
4.816Citations (PDF)
185Unexpected effects of early-life adversity and social enrichment on the anxiety profile of mice varying in serotonin transporter genotype
Behavioural Brain Research, 2013, 247, 248-258
2.318Citations (PDF)
186To attack, or not to attack? The role of serotonin transporter genotype in the display of maternal aggression
Behavioural Brain Research, 2013, 242, 135-141
2.319Citations (PDF)
187Bipolar disorder risk alleles in children with ADHD
Journal of Neural Transmission, 2013, 120, 1611-1617
3.614Citations (PDF)
188Impact of the ADHD-susceptibility gene CDH13 on development and function of brain networks0.985Citations (PDF)
189Acetylcholine-metabolizing butyrylcholinesterase (BCHE) copy number and single nucleotide polymorphisms and their role in attention-deficit/hyperactivity syndrome
Journal of Psychiatric Research, 2013, 47, 1902-1908
3.113Citations (PDF)
190The interplay of genotype and environment in the development of fear and anxiety
E-Neuroforum, 2013, 19, 57-62
0.21Citations (PDF)
191Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
Nature Genetics, 2013, 45, 984-994
16.31,837Citations (PDF)
192Vulnerability versus resilience to prenatal stress in male and female rats; Implications from gene expression profiles in the hippocampus and frontal cortex0.989Citations (PDF)
193COMT × DRD4 Epistasis Impacts Prefrontal Cortex Function Underlying Response Control
Cerebral Cortex, 2013, 23, 1453-1462
2.933Citations (PDF)
194Dances with black widow spiders: Dysregulation of glutamate signalling enters centre stage in ADHD0.957Citations (PDF)
195Influence of a Latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD)0.934Citations (PDF)
196Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety2.0113Citations (PDF)
197KCNIP4 as a candidate gene for personality disorders and adult ADHD0.931Citations (PDF)
198The genome of the platyfish, Xiphophorus maculatus, provides insights into evolutionary adaptation and several complex traits
Nature Genetics, 2013, 45, 567-572
16.3214Citations (PDF)
199High Loading of Polygenic Risk for ADHD in Children With Comorbid Aggression
American Journal of Psychiatry, 2013, 170, 909-916
10.5118Citations (PDF)
200Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity
Brain, 2013, 136, 483-493
8.966Citations (PDF)
201Common obesity risk alleles in childhood attention‐deficit/hyperactivity disorder1.876Citations (PDF)
202Haplotype co‐segregation with attention deficit‐hyperactivity disorder in unrelated german multi‐generation families1.81Citations (PDF)
203Effect of Acute Stressor and Serotonin Transporter Genotype on Amygdala First Wave Transcriptome in Mice
PLoS ONE, 2013, 8, e58880
2.511Citations (PDF)
204Conservation of 5-HT1A receptor-mediated autoinhibition of serotonin (5-HT) neurons in mice with altered 5-HT homeostasis4.028Citations (PDF)
205Effects of repeated adolescent stress and serotonin transporter gene partial knockout in mice on behaviors and brain structures relevant to major depression2.511Citations (PDF)
206Das Zusammenspiel von Genotyp und Umwelt bei der Entwicklung von Furcht und Angst
E-Neuroforum, 2013, 19, 104-109
0.23Citations (PDF)
207SPOCK3, a risk gene for adult ADHD and personality disorders2.920Citations (PDF)
2085-HTT Deficiency Affects Neuroplasticity and Increases Stress Sensitivity Resulting in Altered Spatial Learning Performance in the Morris Water Maze but Not in the Barnes Maze
PLoS ONE, 2013, 8, e78238
2.544Citations (PDF)
209Serotonin (5-HT) in the Regulation of Depression-Related Emotionality: Insight from 5-HT Transporter and Tryptophan Hydroxylase-2 Knockout Mouse Models
Current Drug Targets, 2013, 14, 549-570
2.038Citations (PDF)
210Neurotransmitter Reuptake Mechanisms
CNS Drugs, 2012, 4, 302-322
6.85Citations (PDF)
211Association of a functional variant of the nitric oxide synthase 1 gene with personality, anxiety, and depressiveness
Development and Psychopathology, 2012, 24, 1225-1235
3.624Citations (PDF)
212Genome-Wide Analysis of Copy Number Variants in Attention Deficit Hyperactivity Disorder: The Role of Rare Variants and Duplications at 15q13.3
American Journal of Psychiatry, 2012, 169, 195-204
10.5226Citations (PDF)
213An association study of sequence variants in the forkhead box P2 (FOXP2) gene and adulthood attention-deficit/hyperactivity disorder in two European samples
Psychiatric Genetics, 2012, 22, 155-160
1.415Citations (PDF)
214Genetic variation in 5-hydroxytryptamine transporter expression causes adaptive changes in 5-HT4 receptor levels2.017Citations (PDF)
215Children under stress – COMT genotype and stressful life events predict cortisol increase in an acute social stress paradigm2.068Citations (PDF)
216Serotonin in the Modulation of Neural Plasticity and Networks: Implications for Neurodevelopmental Disorders
Neuron, 2012, 76, 175-191
12.8330Citations (PDF)
217Avances en enfoques multidisciplinarios y en diversas especies para el examen de la neurobiología de los trastornos psiquiátricos
Psiquiatria Biologica, 2012, 19, 9-20
0.10Citations (PDF)
218Establishing a learned-helplessness effect paradigm in C57BL/6 mice: Behavioural evidence for emotional, motivational and cognitive effects of aversive uncontrollability per se
Neuropharmacology, 2012, 62, 358-372
4.542Citations (PDF)
219The ADHD-linked gene Lphn3.1 controls locomotor activity and impulsivity in zebrafish
Molecular Psychiatry, 2012, 17, 855-855
8.321Citations (PDF)
220Genetic contributions to acute autonomic stress responsiveness in children1.035Citations (PDF)
221Targeting brain serotonin synthesis: insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour4.1116Citations (PDF)
222Candidate system analysis in ADHD: Evaluation of nine genes involved in dopaminergic neurotransmission identifies association with<i>DRD1</i>3.928Citations (PDF)
223Randomness of resting-state brain oscillations encodes Gray's personality trait
NeuroImage, 2012, 59, 1842-1845
4.842Citations (PDF)
224Establishing a probabilistic reversal learning test in mice: Evidence for the processes mediating reward-stay and punishment-shift behaviour and for their modulation by serotonin
Neuropharmacology, 2012, 63, 1012-1021
4.549Citations (PDF)
225A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity
Psychopharmacology, 2012, 224, 573-579
3.032Citations (PDF)
226Expression of Monoamine Transporters, Nitric Oxide Synthase 3, and Neurotrophin Genes in Antidepressant-Stimulated Astrocytes2.716Citations (PDF)
227The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development
Molecular Psychiatry, 2012, 17, 946-954
8.3138Citations (PDF)
228PPP2R2C as a candidate gene of a temperament and character trait-based endophenotype of ADHD2.68Citations (PDF)
229Pilot study: potential transcription markers for adult attention-deficit hyperactivity disorder in whole blood2.67Citations (PDF)
230Epigenetic epidemiology in psychiatry: A translational neuroscience perspective1.83Citations (PDF)
231Serotonergic innervation and serotonin receptor expression of NPY-producing neurons in the rat lateral and basolateral amygdaloid nuclei
Brain Structure and Function, 2012, 218, 421-435
2.756Citations (PDF)
232GABA concentration and GABAergic neuron populations in limbic areas are differentially altered by brain serotonin deficiency in Tph2 knockout mice2.035Citations (PDF)
233Dopamine D4 receptor gene variation impacts self-reported altruism
Molecular Psychiatry, 2012, 18, 402-403
8.324Citations (PDF)
234Impacts of Brain Serotonin Deficiency following Tph2 Inactivation on Development and Raphe Neuron Serotonergic Specification
PLoS ONE, 2012, 7, e43157
2.589Citations (PDF)
235Integrating Neurobiological Markers of Depression14.4122Citations (PDF)
236Looking on the Bright Side of Serotonin Transporter Gene Variation
Biological Psychiatry, 2011, 69, 513-519
1.7357Citations (PDF)
237A lifetime of attention-deficit/hyperactivity disorder: diagnostic challenges, treatment and neurobiological mechanisms3.237Citations (PDF)
238The winner and loser effect, serotonin transporter genotype, and the display of offensive aggression
Physiology and Behavior, 2011, 103, 565-574
2.424Citations (PDF)
239Olfactory deficits in deletion syndrome 22q11.2
Schizophrenia Research, 2011, 129, 220-221
2.411Citations (PDF)
240Interaction of Serotonin Transporter Gene-Linked Polymorphic Region and Stressful Life Events Predicts Cortisol Stress Response
Neuropsychopharmacology, 2011, 36, 1332-1339
5.472Citations (PDF)
241On the role of serotonin and effort in voluntary attention: Evidence of genetic variation in N1 modulation
Behavioural Brain Research, 2011, 216, 122-128
2.346Citations (PDF)
242Gene–environment interaction influences anxiety-like behavior in ethologically based mouse models
Behavioural Brain Research, 2011, 218, 99-105
2.340Citations (PDF)
243Serotonin transporter knockout and repeated social defeat stress: Impact on neuronal morphology and plasticity in limbic brain areas
Behavioural Brain Research, 2011, 220, 42-54
2.344Citations (PDF)
244Away game or home match: The influence of venue and serotonin transporter genotype on the display of offensive aggression
Behavioural Brain Research, 2011, 219, 291-301
2.325Citations (PDF)
245The COGITAT holeboard system as a valuable tool to assess learning, memory and activity in mice
Behavioural Brain Research, 2011, 220, 152-158
2.311Citations (PDF)
246Altered expression of neuronal tryptophan hydroxylase-2 mRNA in the dorsal and median raphe nuclei of three genetically modified mouse models relevant to depression and anxiety2.012Citations (PDF)
247Serotonin transporter deficiency protects mice from mechanical allodynia and heat hyperalgesia in vincristine neuropathy
Neuroscience Letters, 2011, 495, 93-97
1.931Citations (PDF)
248Predicting cortisol stress responses in older individuals: Influence of serotonin receptor 1A gene (HTR1A) and stressful life events
Hormones and Behavior, 2011, 60, 105-111
2.435Citations (PDF)
249Living in a dangerous world decreases maternal care: A study in serotonin transporter knockout mice
Hormones and Behavior, 2011, 60, 397-407
2.431Citations (PDF)
250A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception
Neuroscience, 2011, 175, 315-327
2.527Citations (PDF)
251Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout mice0.958Citations (PDF)
252Epistatic interaction of CREB1 and KCNJ6 on rumination and negative emotionality0.925Citations (PDF)
253Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression0.912Citations (PDF)
254Differential gene expression in mutant mice overexpressing or deficient in the serotonin transporter: A focus on urocortin 10.98Citations (PDF)
255Cerebral metabolic responses to 5-HT2A/C receptor activation in mice with genetically modified serotonin transporter (SERT) expression0.911Citations (PDF)
256Advances in multidisciplinary and cross-species approaches to examine the neurobiology of psychiatric disorders0.928Citations (PDF)
257Adult Raphe-Specific Deletion of Lmx1b Leads to Central Serotonin Deficiency
PLoS ONE, 2011, 6, e15998
2.564Citations (PDF)
258Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade
PLoS ONE, 2011, 6, e20567
2.5104Citations (PDF)
259ADHD related behaviors are associated with brain activation in the reward system
Neuropsychologia, 2011, 49, 426-434
1.863Citations (PDF)
260Serotonergic modulation in executive functioning: Linking genetic variations to working memory performance
Neuropsychologia, 2011, 49, 3776-3785
1.863Citations (PDF)
261A novel BDNF polymorphism affects plasma protein levels in interaction with early adversity in rhesus macaques
Psychoneuroendocrinology, 2011, 36, 372-379
2.517Citations (PDF)
262Tryptophan hydroxylase-2 (TPH2) in disorders of cognitive control and emotion regulation: A perspective
Psychoneuroendocrinology, 2011, 36, 393-405
2.5107Citations (PDF)
263Methylphenidate normalizes emotional processing in adult patients with attention-deficit/hyperactivity disorder: Preliminary findings
Brain Research, 2011, 1381, 159-166
2.525Citations (PDF)
264Variation in genes involved in dopamine clearance influence the startle response in older adults
Journal of Neural Transmission, 2011, 118, 1281-1292
3.615Citations (PDF)
265Olfactory and gustatory sensitivity in adults with attention-deficit/hyperactivity disorder2.626Citations (PDF)
266No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample2.68Citations (PDF)
2675-Hydroxyindolacetic Acid (5-HIAA), a Main Metabolite of Serotonin, is Responsible for Complete Freund's Adjuvant-Induced Thermal Hyperalgesia in Mice
Molecular Pain, 2011, 7,
2.522Citations (PDF)
268Influence of a genetic variant of the neuronal growth associated protein Stathmin 1 on cognitive and affective control processes: An event‐related potential study1.830Citations (PDF)
269Exploring <i>DRD4</i> and its interaction with <i>SLC6A3</i> as possible risk factors for adult ADHD: A meta‐analysis in four European populations1.823Citations (PDF)
270Genome‐wide association study in German patients with attention deficit/hyperactivity disorder1.872Citations (PDF)
271Association between reward‐related activation in the ventral striatum and trait reward sensitivity is moderated by dopamine transporter genotype
Human Brain Mapping, 2011, 32, 1557-1565
3.865Citations (PDF)
272Recovery and aging of serotonergic fibers after single and intermittent MDMA treatment in dark agouti rat
Journal of Comparative Neurology, 2011, 519, 2353-2378
2.115Citations (PDF)
273Cross-Disorder Analysis of Bipolar Risk Genes: Further Evidence of DGKH as a Risk Gene for Bipolar Disorder, but also Unipolar Depression and Adult ADHD
Neuropsychopharmacology, 2011, 36, 2076-2085
5.493Citations (PDF)
274When the Serotonin Transporter Gene Meets Adversity: The Contribution of Animal Models to Understanding Epigenetic Mechanisms in Affective Disorders and Resilience0.064Citations (PDF)
275Neurovascular Coupling in the Human Visual Cortex Is Modulated by Cyclooxygenase-1 (COX-1) Gene Variant
Cerebral Cortex, 2011, 21, 1659-1666
2.922Citations (PDF)
276A functional promoter polymorphism of neuronal nitric oxide synthase moderates prefrontal functioning in schizophrenia2.029Citations (PDF)
277DIRAS2 is Associated with Adult ADHD, Related Traits, and Co-Morbid Disorders
Neuropsychopharmacology, 2011, 36, 2318-2327
5.439Citations (PDF)
278Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder
Nature Genetics, 2011, 44, 78-84
16.3322Citations (PDF)
279Epigenetic regulation of the BDNF gene: implications for psychiatric disorders
Molecular Psychiatry, 2011, 17, 584-596
8.3244Citations (PDF)
280Differential Effects of Prenatal Stress in 5-Htt Deficient Mice: Towards Molecular Mechanisms of Gene × Environment Interactions
PLoS ONE, 2011, 6, e22715
2.566Citations (PDF)
281<i>Stathmin</i>, a gene regulating neural plasticity, affects fear and anxiety processing in humans1.838Citations (PDF)
282Early attentional deficits in an attention-to-prepulse paradigm in ADHD adults.
Journal of Abnormal Psychology, 2010, 119, 594-603
4.431Citations (PDF)
283The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity
Psychopharmacology, 2010, 209, 255-261
3.034Citations (PDF)
284The expression of the transcription factor FEV in adult human brain and its association with affective disorders
Journal of Neural Transmission, 2010, 117, 831-836
3.69Citations (PDF)
285Reduced NoGo-anteriorisation during continuous performance test in deletion syndrome 22q11.23.17Citations (PDF)
286The role of the serotonin transporter polymorphism for the endocrine stress response in newborns
Psychoneuroendocrinology, 2010, 35, 289-296
2.573Citations (PDF)
287Functional variants of <i>TSPAN8</i> are associated with bipolar disorder and schizophrenia1.829Citations (PDF)
288Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations1.820Citations (PDF)
289Non‐linear relationship between 5‐HT transporter gene expression and frequency sensitivity of 5‐HT signals
Journal of Neurochemistry, 2010, 115, 965-973
4.037Citations (PDF)
290Lack of the serotonin transporter in mice reduces locomotor activity and leads to gender-dependent late onset obesity3.137Citations (PDF)
291Impact of the AHI1 Gene on the Vulnerability to Schizophrenia: A Case-Control Association Study
PLoS ONE, 2010, 5, e12254
2.521Citations (PDF)
292The role of serotonin transporter in modeling psychiatric disorders: focus on depression, emotion regulation, and the social brain
2010, , 308-352
3Citations (PDF)
293Dopamine Transporter (SLC6A3) Genotype Impacts Neurophysiological Correlates of Cognitive Response Control in an Adult Sample of Patients with ADHD
Neuropsychopharmacology, 2010, 35, 2193-2202
5.436Citations (PDF)
294Increased vulnerability to psychosocial stress in heterozygous serotonin transporter knockout mice2.793Citations (PDF)
295Serotonin Kompakt – Teil 10.420Citations (PDF)
296Serotonin Kompakt – Teil 20.41Citations (PDF)
297Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder0.6366Citations (PDF)
298Case-Control Genome-Wide Association Study of Attention-Deficit/Hyperactivity Disorder0.6143Citations (PDF)
299Functional Amygdala-Hippocampus Connectivity During Anticipation of Aversive Events is Associated with Gray's Trait “Sensitivity to Punishment”
Biological Psychiatry, 2010, 68, 459-464
1.746Citations (PDF)
300Brain-specific conditional and time-specific inducible Tph2 knockout mice possess normal serotonergic gene expression in the absence of serotonin during adult life
Neurochemistry International, 2010, 57, 512-517
3.640Citations (PDF)
301Influence of functional tryptophan hydroxylase 2 gene variation and sex on the startle response in children, young adults, and older adults
Biological Psychology, 2010, 83, 214-221
2.724Citations (PDF)
302Modulation of behavioural profile and stress response by 5-HTT genotype and social experience in adulthood
Behavioural Brain Research, 2010, 207, 21-29
2.381Citations (PDF)
303Social status and day-to-day behaviour of male serotonin transporter knockout mice
Behavioural Brain Research, 2010, 211, 220-228
2.359Citations (PDF)
304A functional NOS1 promoter polymorphism interacts with adverse environment on functional and dysfunctional impulsivity
Psychopharmacology, 2010, 214, 239-248
3.040Citations (PDF)
305Ultrastructural characterization of tryptophan hydroxylase 2-specific cortical serotonergic fibers and dorsal raphe neuronal cell bodies after MDMA treatment in rat
Psychopharmacology, 2010, 213, 377-391
3.019Citations (PDF)
306Living in a dangerous world: the shaping of behavioral profile by early environment and 5-HTT genotype2.560Citations (PDF)
307Panic disorder and a possible treatment approach by means of high-frequency rTMS: A case report3.933Citations (PDF)
308Influence of Functional Variant of Neuronal Nitric Oxide Synthase on Impulsive Behaviors in Humans14.4129Citations (PDF)
309Altered Sleep Homeostasis after Restraint Stress in<i>5-HTT</i>Knock-Out Male Mice: A Role for Hypocretins
Journal of Neuroscience, 2009, 29, 15575-15585
3.723Citations (PDF)
310Wirksamkeit und Wirkmechanismen von Psychotherapie bei der Behandlung der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) bei Kindern und Erwachsenen0.67Citations (PDF)
311Exploring the genetic link between RLS and ADHD3.131Citations (PDF)
312Regional brain activation changes and abnormal functional connectivity of the ventrolateral prefrontal cortex during working memory processing in adults with attention‐deficit/hyperactivity disorder
Human Brain Mapping, 2009, 30, 2252-2266
3.8140Citations (PDF)
313Decreased anxiety in mice lacking the organic cation transporter 3
Journal of Neural Transmission, 2009, 116, 689-697
3.652Citations (PDF)
314Genetic variation of serotonin receptor function affects prepulse inhibition of the startle
Journal of Neural Transmission, 2009, 116, 607-613
3.618Citations (PDF)
315Catechol-O-methyltransferase Val158Met genotype affects neural correlates of aversive stimuli processing2.032Citations (PDF)
316Influence of SLC6A3 and COMT variation on neural activation during response inhibition
Biological Psychology, 2009, 81, 144-152
2.789Citations (PDF)
317Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice
Neuroscience, 2009, 162, 870-880
2.548Citations (PDF)
318Neural Hyporesponsiveness and Hyperresponsiveness During Immediate and Delayed Reward Processing in Adult Attention-Deficit/Hyperactivity Disorder
Biological Psychiatry, 2009, 65, 7-14
1.7234Citations (PDF)
319Abnormal Affective Responsiveness in Attention-Deficit/Hyperactivity Disorder: Subtype Differences
Biological Psychiatry, 2009, 65, 578-585
1.748Citations (PDF)
320Case-Control Study of Six Genes Asymmetrically Expressed in the Two Cerebral Hemispheres: Association of BAIAP2 with Attention-Deficit/Hyperactivity Disorder
Biological Psychiatry, 2009, 66, 926-934
1.755Citations (PDF)
321Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: Convergent data from Tph2 knockout mice0.9132Citations (PDF)
322Neural response to reward anticipation is modulated by Gray's impulsivity
NeuroImage, 2009, 46, 1148-1153
4.8118Citations (PDF)
323Interaction effect of D4 dopamine receptor gene and serotonin transporter promoter polymorphism on the cortisol stress response.
Behavioral Neuroscience, 2009, 123, 1288-1295
1.343Citations (PDF)
324Serotonin transporter gene variation and stressful life events impact processing of fear and anxiety2.036Citations (PDF)
325A gene–environment investigation on personality traits in two independent clinical sets of adult patients with personality disorder and attention deficit/hyperactive disorder2.931Citations (PDF)
326Multicenter Analysis of the SLC6A3/DAT1 VNTR Haplotype in Persistent ADHD Suggests Differential Involvement of the Gene in Childhood and Persistent ADHD
Neuropsychopharmacology, 2009, 35, 656-664
5.4168Citations (PDF)
327Serotonin Depletion Hampers Survival and Proliferation in Neurospheres Derived from Adult Neural Stem Cells
Neuropsychopharmacology, 2009, 35, 893-903
5.441Citations (PDF)
328Neurobiologie des Aufmerksamkeitsdefizit-/Hyperaktivitätssyndroms
Der Nervenarzt, 2008, 79, 771-781
0.931Citations (PDF)
329Allelic variants of SNAP25 in a family-based sample of ADHD
Journal of Neural Transmission, 2008, 115, 317-321
3.622Citations (PDF)
330Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice
Journal of Neural Transmission, 2008, 115, 1127-1132
3.6150Citations (PDF)
331Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies
Journal of Neural Transmission, 2008, 115, 1573-1585
3.6332Citations (PDF)
332Reduced thermal hyperalgesia and enhanced peripheral nerve injury after hind paw inflammation in mice lacking the serotonin‐transporter
European Journal of Pain, 2008, 12, 790-797
3.227Citations (PDF)
333Targeting the murine serotonin transporter: insights into human neurobiology10.0386Citations (PDF)
334Identifying Molecular Substrates in a Mouse Model of the Serotonin Transporter × Environment Risk Factor for Anxiety and Depression
Biological Psychiatry, 2008, 63, 840-846
1.7127Citations (PDF)
335Association of a NOS1 promoter repeat with Alzheimer's disease
Neurobiology of Aging, 2008, 29, 1359-1365
3.429Citations (PDF)
336How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems
Neuropharmacology, 2008, 55, 932-960
4.5185Citations (PDF)
337Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on neural correlates of affective processing
Biological Psychology, 2008, 79, 118-125
2.771Citations (PDF)
338Expression analysis for inverted effects of serotonin transporter inactivation2.110Citations (PDF)
339Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice2.037Citations (PDF)
340Analysis of the Stathmin rs182455 Single Nucleotide Promoter Polymorphism in Patients with Multiple Sclerosis
Journal of Neurogenetics, 2008, 22, 181-186
2.03Citations (PDF)
341Serotonergic gene inactivation in mice: models for anxiety and aggression?1.026Citations (PDF)
342Environmental Risk Factors and Attention-Deficit/Hyperactivity Disorder Symptoms14.42Citations (PDF)
343Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions
Behavioural Pharmacology, 2008, 19, 566-574
3.8159Citations (PDF)
344Functional Analysis of a Potassium-Chloride Co-Transporter 3 (SLC12A6) Promoter Polymorphism Leading to an Additional DNA Methylation Site
Neuropsychopharmacology, 2008, 34, 458-467
5.434Citations (PDF)
345A functional dopamine-β-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders
Journal of Neural Transmission, 2008, 116, 121-130
3.689Citations (PDF)
346Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals
Molecular Psychiatry, 2008, 14, 1032-1039
8.371Citations (PDF)
347Impaired Stress-Coping and Fear Extinction and Abnormal Corticolimbic Morphology in Serotonin Transporter Knock-Out Mice
Journal of Neuroscience, 2007, 27, 684-691
3.7323Citations (PDF)
348Genetic Variation of Serotonin Function and Cognitive Control2.368Citations (PDF)
349Interaction between BDNF Val66Met and Dopamine Transporter Gene Variation Influences Anxiety-Related Traits
Neuropsychopharmacology, 2007, 32, 2552-2560
5.4114Citations (PDF)
350Altered Neocortical Cell Density and Layer Thickness in Serotonin Transporter Knockout Mice: A Quantitation Study
Cerebral Cortex, 2007, 17, 1394-1401
2.967Citations (PDF)
351Neuronal nitric oxide synthase (NOS-I) knockout increases the survival rate of neural cells in the hippocampus independentlyof BDNF2.227Citations (PDF)
352NO synthase-positive striatal interneurons are decreased in schizophrenia0.912Citations (PDF)
353Nature and Nurture Predispose to Violent Behavior: Serotonergic Genes and Adverse Childhood Environment
Neuropsychopharmacology, 2007, 32, 2375-2383
5.4209Citations (PDF)
354Serotonin-1A Receptor Gene HTR1A Variation Predicts Interferon-Induced Depression in Chronic Hepatitis C
Gastroenterology, 2007, 132, 1279-1286
1.094Citations (PDF)
355MLC1 Polymorphisms Are Specifically Associated with Periodic Catatonia, a Subgroup of Chronic Schizophrenia
Biological Psychiatry, 2007, 61, 1211-1214
1.725Citations (PDF)
3563,4-Methylenedioxymethamphetamine Self-Administration is Abolished in Serotonin Transporter Knockout Mice
Biological Psychiatry, 2007, 62, 669-679
1.777Citations (PDF)
357Long story short: the serotonin transporter in emotion regulation and social cognition
Nature Neuroscience, 2007, 10, 1103-1109
12.4878Citations (PDF)
358Linking emotion to the social brain
EMBO Reports, 2007, 8,
5.369Citations (PDF)
359Association and linkage of allelic variants of the dopamine transporter gene in ADHD
Molecular Psychiatry, 2007, 12, 923-933
8.373Citations (PDF)
360Dopamine and cognitive control: the prospect of monetary gains influences the balance between flexibility and stability in a set‐shifting paradigm3.775Citations (PDF)
361An Adenosine A2A Receptor Gene Haplotype is Associated with Migraine With Aura
Cephalalgia, 2007, 27, 177-181
4.434Citations (PDF)
362Dopamine and cognitive control: The influence of spontaneous eyeblink rate, DRD4 exon III polymorphism and gender on flexibility in set-shifting
Brain Research, 2007, 1131, 155-162
2.563Citations (PDF)
363Methamphetamine-induced hyperthermia and lethal toxicity: Role of the dopamine and serotonin transporters4.468Citations (PDF)
364Behavioural and expressional phenotyping of nitric oxide synthase-I knockdown animals
2007, , 69-85
40Citations (PDF)
365A pharmacological analysis of mice with a targeted disruption of the serotonin transporter
Psychopharmacology, 2007, 195, 147-166
3.059Citations (PDF)
366No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD
Journal of Neural Transmission, 2007, 114, 523-526
3.633Citations (PDF)
367Functional polymorphisms of the 5-HT1A and 5-HT1B receptor are associated with clinical symptoms in migraineurs
Journal of Neural Transmission, 2007, 114, 1227-1232
3.610Citations (PDF)
368Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center2.9191Citations (PDF)
369FZD3 is not a risk gene for schizophrenia: a case-control study in a Caucasian sample
2007, , 297-301
6Citations (PDF)
370Unaltered susceptibility to scrapie in serotonin transporter deficient mice
Neurochemistry International, 2006, 49, 454-458
3.61Citations (PDF)
371Aberrant accumulation of serotonin in dopaminergic neurons
Neuroscience Letters, 2006, 401, 49-54
1.926Citations (PDF)
372Serotonin transporter gene polymorphism (5-HTTLPR) and emotional response to auditory hallucinations in schizophrenia2.012Citations (PDF)
373A NOS-III haplotype that includes functional polymorphisms is associated with bipolar disorder2.032Citations (PDF)
374Gender-Dependent Modulation of Brain Monoamines and Anxiety-Like Behaviors in Mice with Genetic Serotonin Transporter and BDNF Deficiencies4.10Citations (PDF)
375Toxicity and Metabolism of the Chloral-Derived Mammalian Alkaloid 1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) in PC12 Cells1.85Citations (PDF)
376Interaction of serotonergic and noradrenergic gene variants in panic disorder
Psychiatric Genetics, 2006, 16, 59-65
1.442Citations (PDF)
377A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function
Molecular Psychiatry, 2006, 11, 286-300
8.3192Citations (PDF)
378Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531
Molecular Psychiatry, 2006, 11, 224-226
8.3474Citations (PDF)
379Neural stem cell proliferation is decreased in schizophrenia, but not in depression
Molecular Psychiatry, 2006, 11, 514-522
8.3533Citations (PDF)
380Serotonin transporter gene variation impacts innate fear processing: acoustic startle response and emotional startle
Molecular Psychiatry, 2006, 11, 1106-1112
8.378Citations (PDF)
381Gender-Dependent Modulation of Brain Monoamines and Anxiety-like Behaviors in Mice with Genetic Serotonin Transporter and BDNF Deficiencies4.185Citations (PDF)
382The Wuerzburg Research Initiative on Adult Attention-Deficit/Hyperactivity Disorder (WURIN-AADHD): Multi-layered evaluation of long-term course2.95Citations (PDF)
383Gender-dependent regulation of G-protein-gated inwardly rectifying potassium current in dorsal raphe neurons inknock-out mice devoid of the 5-hydroxytryptamine transporter
Journal of Neurobiology, 2006, 66, 1475-1488
3.913Citations (PDF)
384Reversible ischaemic neurological deficit associated with short-term methylphenidate medication2.01Citations (PDF)
385Further Evidence for an Association of 5-HTTLPR with Intensity Dependence of Auditory-Evoked Potentials
Neuropsychopharmacology, 2006, 31, 2047-2054
5.438Citations (PDF)
386The novel brain-specific tryptophan hydroxylase-2 gene in panic disorder5.834Citations (PDF)
387Additive Effects of Serotonin Transporter and Tryptophan Hydroxylase-2 Gene Variation on Emotional Processing
Cerebral Cortex, 2006, 17, 1160-1163
2.983Citations (PDF)
388Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive–compulsive disorder2.088Citations (PDF)
389Neural correlates of epigenesis7.7271Citations (PDF)
390Early Life Blockade of 5-Hydroxytryptamine 1A Receptors Normalizes Sleep and Depression-Like Behavior in Adult Knock-Out Mice Lacking the Serotonin Transporter
Journal of Neuroscience, 2006, 26, 5554-5564
3.7103Citations (PDF)
391Impact of Catechol-O-Methyltransferase on Prefrontal Brain Functioning in Schizophrenia Spectrum Disorders
Neuropsychopharmacology, 2006, 32, 162-170
5.451Citations (PDF)
392Genetik von Alkoholmissbrauch und -abhängigkeit bei adultem ADHS
Sucht, 2006, 52, 376-385
0.70Citations (PDF)
393Brain-derived neurotrophic factor V66M polymorphism in childhood-onset obsessive–compulsive disorder2.027Citations (PDF)
394Rare variants of the gene encoding the potassium chloride co-transporter 3 are associated with bipolar disorder2.026Citations (PDF)
395Dopamine and Cognitive Control: The Influence of Spontaneous Eyeblink Rate and Dopamine Gene Polymorphisms on Perseveration and Distractibility.
Behavioral Neuroscience, 2005, 119, 483-490
1.3154Citations (PDF)
396A Highly Polymorphic Poly-Glutamine Stretch in the Potassium Channel KCNN3 in Migraine
Headache, 2005, 45, 132-136
3.319Citations (PDF)
397Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE3.544Citations (PDF)
398Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder
Molecular Psychiatry, 2005, 10, 1126-1132
8.3132Citations (PDF)
399Alcohol dependence and gene x environment interaction in emotion regulation: Is serotonin the link?4.472Citations (PDF)
400Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice3.3111Citations (PDF)
401Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation
Journal of Neural Transmission, 2005, 112, 1479-1485
3.6156Citations (PDF)
402Cluster B Personality Disorders are Associated with Allelic Variation of Monoamine Oxidase A Activity
Neuropsychopharmacology, 2005, 30, 1711-1718
5.464Citations (PDF)
403Beyond affect: A role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task7.7302Citations (PDF)
404Pharmacogenetics of the serotonin transporter4.1133Citations (PDF)
405Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses4.170Citations (PDF)
406Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter
Neuropharmacology, 2005, 49, 798-810
4.5155Citations (PDF)
407The Corticotropin-Releasing Factor (CRF)-system and monoaminergic afferents in the central amygdala: Investigations in different mouse strains and comparison with the rat
Neuroscience, 2005, 131, 953-967
2.578Citations (PDF)
408Monoamine oxidase A gene promoter variation and rearing experience influences aggressive behavior in rhesus monkeys
Biological Psychiatry, 2005, 57, 167-172
1.7219Citations (PDF)
409No causative DLL4 mutations in periodic catatonia patients from 15q15 linked families
Schizophrenia Research, 2005, 75, 1-3
2.44Citations (PDF)
410Differential Functional Variability of Serotonin Transporter and Monoamine Oxidase A Genes in Macaque Species Displaying Contrasting Levels of Aggression-Related Behavior
Behavior Genetics, 2005, 36, 163-172
1.8100Citations (PDF)
411Interaction Between Serotonin Transporter Gene Variation and RearingCondition in Alcohol Preference and Consumption in Female Primates14.4228Citations (PDF)
412Sexual dichotomy of an interaction between early adversity and the serotonin transporter gene promoter variant in rhesus macaques7.7183Citations (PDF)
413Allelic Variation of Serotonin Transporter Function Modulates the Brain Electrical Response for Error Processing
Neuropsychopharmacology, 2004, 29, 1506-1511
5.4100Citations (PDF)
414Regional Differences in Extracellular Dopamine and Serotonin Assessed by In Vivo Microdialysis in Mice Lacking Dopamine and/or Serotonin Transporters
Neuropsychopharmacology, 2004, 29, 1790-1799
5.4185Citations (PDF)
415Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour3.794Citations (PDF)
416GABAB receptors in 5-HT transporter- and 5-HT1A receptor-knock-out mice: further evidence of a transduction pathway shared with 5-HT1A receptors
Journal of Neurochemistry, 2004, 89, 886-896
4.032Citations (PDF)
417Adaption of the serotoninergic neuronal phenotype in the absence of 5-HT autoreceptors or the 5-HT transporter: involvement of BDNF and cAMP3.747Citations (PDF)
418Altered functioning of the cingulate gyrus in two cases of chromosome 22q11 deletion syndrome1.96Citations (PDF)
419Association analysis of the functional monoamine oxidase A gene promotor polymorphism in migraine
Journal of Neural Transmission, 2004, 111, 603-609
3.615Citations (PDF)
420Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques
Biological Psychiatry, 2004, 55, 733-738
1.7360Citations (PDF)
421Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics2.081Citations (PDF)
422Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women2.0141Citations (PDF)
423Encephalopathy and myoclonus triggered by valproic acid4.119Citations (PDF)
424Duplication 15q14 → pter: a rare chromosomal abnormality underlying bipolar affective disorder
European Psychiatry, 2004, 19, 179-181
0.38Citations (PDF)
425Association Between Allelic Variation of Serotonin Transporter Function and Neuroticism in Anxious Cluster C Personality Disorders
American Journal of Psychiatry, 2004, 161, 569-572
10.564Citations (PDF)
426Association of a functional −1019C&gt;G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia2.0100Citations (PDF)
427Dopamine D4 receptor exon III genotype influence on the auditory evoked novelty P3
NeuroReport, 2004, 15, 2411-2415
1.526Citations (PDF)
428Serotonin Transporter: Gene, Genetic Disorders, and Pharmacogenetics5.0366Citations (PDF)
429Roles for Serotonin in Neurodevelopment: More than just Neural Transmission
Current Neuropharmacology, 2004, 2, 403-417
4.233Citations (PDF)
430Antidepressants and gene expression profiling: how to SNARE novel drug targets
Pharmacogenomics Journal, 2003, 2, 346-348
3.114Citations (PDF)
431The genomic organization of the murine Mlc1 ( Wkl1 , KIAA0027 ) gene
Journal of Neural Transmission, 2003, 110, 333-343
3.67Citations (PDF)
432Allelic variation in 5-HT 1A receptor expression is associated with anxiety- and depression-related personality traits
Journal of Neural Transmission, 2003, 110, 1445-1453
3.6189Citations (PDF)
433Anxiety-related traits in mice with modified genes of the serotonergic pathway4.496Citations (PDF)
434The brain-specific protein MLC1 implicated in megalencephalic leukoencephalopathy with subcortical cysts is expressed in glial cells in the murine brain
Glia, 2003, 44, 283-295
5.252Citations (PDF)
435Glucocorticoid‐regulated human serotonin transporter (5‐HTT) expression is modulated by the 5‐HTT gene‐promotor‐linked polymorphic region
Journal of Neurochemistry, 2003, 86, 1072-1078
4.0107Citations (PDF)
436Sex hormone-dependent desensitization of 5-HT1A autoreceptors in knockout mice deficient in the 5-HT transporter3.781Citations (PDF)
437A second large family with catatonic schizophrenia supports the region distally of CHRNA7 on chromosome 15q14–15
Molecular Psychiatry, 2003, 8, 259-260
8.35Citations (PDF)
438Further evidence for a modulation of Novelty Seeking by DRD4 exon III, 5-HTTLPR, and COMT val/met variants
Molecular Psychiatry, 2003, 8, 371-372
8.346Citations (PDF)
439Toward a molecular architecture of personality2.3208Citations (PDF)
440Mice Lacking the Serotonin Transporter Exhibit 5-HT1A Receptor-Mediated Abnormalities in Tests for Anxiety-like Behavior
Neuropsychopharmacology, 2003, 28, 2077-2088
5.4261Citations (PDF)
441ALCOHOL INTAKE AFTER SEROTONIN TRANSPORTER INACTIVATION IN MICE
Alcohol and Alcoholism, 2003, 38, 386-389
1.948Citations (PDF)
442Die Bedeutung der Cadherine bei der Pathogenese schizophrener Erkrankungen0.43Citations (PDF)
443Reduced programmed cell death in brains of serotonin transporter knockout mice
NeuroReport, 2003, , 341-344
1.548Citations (PDF)
444Altered rapid eye movement sleep timing in serotonin transporter knockout mice
NeuroReport, 2003, 14, 233-238
1.564Citations (PDF)
445Absence of Thermal Hyperalgesia in Serotonin Transporter-Deficient Mice
Journal of Neuroscience, 2003, 23, 708-715
3.7104Citations (PDF)
446Quantitation of 5HT3 receptors in forebrain of serotonin transporter deficient mice3.625Citations (PDF)
447Exclusion of the neuronal nicotinic acetylcholine receptor α7 subunit gene as a candidate for catatonic schizophrenia in a large family supporting the chromosome 15q13–22 locus
Molecular Psychiatry, 2002, 7, 220-223
8.324Citations (PDF)
448No missense mutation of WKL1 in a subgroup of probands with schizophrenia
Molecular Psychiatry, 2002, 7, 419-423
8.320Citations (PDF)
449Moclobemide Response in Depressed Patients: Association Study with a Functional Polymorphism in the Monoamine Oxidase A Promoter
Pharmacopsychiatry, 2002, 35, 157-158
3.336Citations (PDF)
450Mutational analysis of the connexin 36 gene (CX36) and exclusion of the coding sequence as a candidate region for catatonic schizophrenia in a large pedigree
Schizophrenia Research, 2002, 58, 87-91
2.426Citations (PDF)
451Synaptotagmin I and IV are differentially regulated in the brain by the recreational drug 3,4-methylenedioxymethamphetamine (MDMA)
Molecular Brain Research, 2002, 108, 94-101
2.813Citations (PDF)
452A splice variant of glutamate transporter GLT1/EAAT2 expressed in neurons: cloning and localization in rat nervous system
Neuroscience, 2002, 109, 45-61
2.5143Citations (PDF)
453Lack of 5-HT1B receptor and of serotonin transporter have different effects on the segregation of retinal axons in the lateral geniculate nucleus compared to the superior colliculus
Neuroscience, 2002, 111, 597-610
2.545Citations (PDF)
454Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions
Neuroscience, 2002, 115, 153-161
2.596Citations (PDF)
455Structural and functional characterization of the human PAX7 5′-flanking regulatory region
Gene, 2002, 294, 259-268
2.415Citations (PDF)
456Norepinephrine transporter gene (NET) variants in patients with panic disorder
Neuroscience Letters, 2002, 333, 41-44
1.922Citations (PDF)
457Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative
Brain Research, 2002, 942, 109-119
2.596Citations (PDF)
458Increased hippocampal DNA oxidation in serotonin transporter deficient mice
Journal of Neural Transmission, 2002, 109, 557-565
3.610Citations (PDF)
459Evolutionary conserved microsatellites in the promoter region of the 5-hydroxytryptamine receptor 2C gene ( HTR2C ) are not associated with bipolar disorder in females
Journal of Neural Transmission, 2002, 109, 939-946
3.618Citations (PDF)
460When cells become depressed: focus on neural stem cells in novel treatment strategies against depression
Journal of Neural Transmission, 2002, 109, 947-962
3.634Citations (PDF)
461No association between dopamine D4 receptor gene exon III and –521C/T polymorphism and Novelty Seeking
Molecular Psychiatry, 2002, 7, 537-538
8.330Citations (PDF)
462Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates
Molecular Psychiatry, 2002, 7, 1058-1063
8.3322Citations (PDF)
463Reply concerning KIAA0027 (WKL1, MLC1) and psychosis: white matters
Molecular Psychiatry, 2002, 7, 1037-1038
8.35Citations (PDF)
464Early experience and serotonin transporter gene variation interact to influence primate CNS function
Molecular Psychiatry, 2002, 7, 118-122
8.362Citations (PDF)
465Variation of serotonergic gene expression: neurodevelopment and the complexity of response to psychopharmacologic drugs0.955Citations (PDF)
466Association analysis of the functional monoamine oxidase a gene promoter polymorphism in psychiatric disorders0.683Citations (PDF)
467Genetic perspectives on the serotonin transporter
Brain Research Bulletin, 2001, 56, 487-494
3.4171Citations (PDF)
468Modulation of serotonin transporter function by interleukin-4
Life Sciences, 2001, 68, 873-880
4.576Citations (PDF)
469Weird world inside the brain
Lancet, The, 2001, 358, S59
35.30Citations (PDF)
470Excessive Activation of Serotonin (5-HT) 1B Receptors Disrupts the Formation of Sensory Maps in Monoamine Oxidase A and 5-HT Transporter Knock-Out Mice
Journal of Neuroscience, 2001, 21, 884-896
3.7237Citations (PDF)
471Functional Consequences of 5-HT Transporter Gene Disruption on 5-HT<sub>1A</sub>Receptor-Mediated Regulation of Dorsal Raphe and Hippocampal Cell Activity
Journal of Neuroscience, 2001, 21, 2178-2185
3.791Citations (PDF)
472Mutational analysis of the neuronal cadherin gene CELSR1 and exclusion as a candidate for catatonic schizophrenia in a large family
Psychiatric Genetics, 2001, 11, 197-200
1.47Citations (PDF)
473Mouse anxiety: the power of knockout
Pharmacogenomics Journal, 2001, 1, 187-192
3.114Citations (PDF)
474Molecular foundation of anxiety disorders
Journal of Neural Transmission, 2001, 108, 717-746
3.638Citations (PDF)
475Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease
Molecular Psychiatry, 2001, 6, 350-352
8.3104Citations (PDF)
476A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree
Molecular Psychiatry, 2001, 6, 302-306
8.390Citations (PDF)
477Serotonergic gene expression and depression: implications for developing novel antidepressants4.772Citations (PDF)
478Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice
Developmental Brain Research, 2001, 126, 125-129
2.242Citations (PDF)
479Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference7.7414Citations (PDF)
480Exonic variants of the GABAB receptor gene and panic disorder
Psychiatric Genetics, 2000, 10, 191-194
1.418Citations (PDF)
481Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample0.6280Citations (PDF)
482Linkage and family-based association study of schizophrenia and the synapsin III locus that maps to chromosome 22q130.633Citations (PDF)
483Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder0.6155Citations (PDF)
484Title is missing!
Neurochemical Research, 2000, 25, 837-843
3.516Citations (PDF)
485Different allele distribution of a regulatory MAOA gene promoter polymorphism in antisocial and anxious-depressive alcoholics
Journal of Neural Transmission, 2000, 107, 681-689
3.677Citations (PDF)
486hKCNN3 which maps to chromosome 1q21 is not the causative gene in periodic catatonia, a familial subtype of schizophrenia2.926Citations (PDF)
487Reduction in the Density and Expression, But Not G-Protein Coupling, of Serotonin Receptors (5-HT<sub>1A</sub>) in 5-HT Transporter Knock-Out Mice: Gender and Brain Region Differences
Journal of Neuroscience, 2000, 20, 7888-7895
3.7204Citations (PDF)
488Novel 5′-regulatory region polymorphisms of the 5-HT2C receptor gene: association study with panic disorder2.030Citations (PDF)
489Serotonergic gene transcriptional control regions: targets for antidepressant drug development?2.039Citations (PDF)
490Polymorphic MAO-A and 5-HT-Transporter Genes: Analysis of Interactions in Panic Disorder3.916Citations (PDF)
491Splitting Schizophrenia: Periodic Catatonia–Susceptibility Locus on Chromosome 15q156.8108Citations (PDF)
492Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF)
Neurochemistry International, 2000, 36, 197-202
3.6154Citations (PDF)
493Pharmacogenetic prediction of clozapine response
Lancet, The, 2000, 355, 1615-1616
35.3295Citations (PDF)
494Differential regulation of adenosine A1 and A2A receptors in serotonin transporter and monoamine oxidase A-deficient mice0.919Citations (PDF)
495Molecular Biology, Pharmacology, and Genetics of the Serotonin Transporter: Psychobiological and Clinical Implications0.012Citations (PDF)
496Splitting Schizophrenia: Periodic Catatonia–Susceptibility Locus on Chromosome 15q156.8183Citations (PDF)
497Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene
Journal of Clinical Investigation, 2000, 105, 1555-1562
9.1274Citations (PDF)
498Serotonin transporter promoter polymorphism influences topography of inhibitory motor control2.064Citations (PDF)
499Knockout Corner: 5-HT1A receptor inactivation: anxiety or depression as a murine experience2.019Citations (PDF)
500Association analysis of a regulatory promoter polymorphism of the PAX-6 gene with idiopathic generalized epilepsy
Epilepsy Research, 1999, 36, 61-67
1.98Citations (PDF)
501Association analysis of aPAX-6gene promoter-associated polymorphic repeat with alcohol dependence
Addiction Biology, 1999, 4, 323-328
2.70Citations (PDF)
502Mosaicism for a serotonin transporter gene promoter-associated deletion: decreased recombination in depression
Journal of Neural Transmission, 1999, 106, 1223-1230
3.633Citations (PDF)
5035-HT1A Receptor Function in Normal Subjects on Clinical Doses of Fluoxetine Blunted Temperature and Hormone Responses to Ipsapirone Challenge
Neuropsychopharmacology, 1999, 20, 628-639
5.472Citations (PDF)
504Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter
Neuroscience Letters, 1999, 262, 113-116
1.997Citations (PDF)
505Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism
Psychiatry Research, 1999, 86, 67-72
3.4166Citations (PDF)
506Gene transfer to the brain: emerging therapeutic strategy in psychiatry?
Biological Psychiatry, 1999, 45, 247-253
1.727Citations (PDF)
507Functional PAX-6 gene-linked polymorphic region: potential association with paranoid schizophrenia
Biological Psychiatry, 1999, 45, 1585-1591
1.718Citations (PDF)
508Excess of High Activity Monoamine Oxidase A Gene Promoter Alleles in Female Patients with Panic Disorder
Human Molecular Genetics, 1999, 8, 621-624
3.1523Citations (PDF)
509Functional Characterization of the HumanPAX3Gene Regulatory Region
Genomics, 1999, 57, 110-119
2.716Citations (PDF)
510A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter
Molecular Psychiatry, 1998, 3, 42-49
8.3216Citations (PDF)
511Hallucinations: psychopathology meets functional genomics
Molecular Psychiatry, 1998, 3, 278-281
8.311Citations (PDF)
512Distribution of the B33 CTG repeat polymorphism in a subtype of schizophrenia2.95Citations (PDF)
513Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene2.946Citations (PDF)
514Insertion/deletion variant (−141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder
Journal of Neural Transmission, 1998, 105, 101-109
3.664Citations (PDF)
515Cloning and functional characterization of the human norepinephrine transporter gene promoter
Journal of Neural Transmission, 1998, 105, 1341-1350
3.635Citations (PDF)
516Regulation of PAX-6 gene transcription: alternate promoter usage in human brain
Molecular Brain Research, 1998, 60, 177-192
2.849Citations (PDF)
517Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6
Neurochemistry International, 1998, 33, 251-254
3.6113Citations (PDF)
518High ethanol tolerance in young adults is associated with the low-activity variant of the promoter of the human serotonin transporter gene
Neuroscience Letters, 1998, 248, 147-150
1.974Citations (PDF)
519Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder
Biological Psychiatry, 1998, 43, 908-912
1.7123Citations (PDF)
520Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?
Biological Psychiatry, 1998, 44, 179-192
1.7294Citations (PDF)
521A Promoter-Associated Polymorphic Repeat ModulatesPAX-6Expression in Human Brain2.143Citations (PDF)
522Role of Serotonin in the Immune System and in Neuroimmune Interactions4.3376Citations (PDF)
523Review : Serotonin Transporter and Psychiatric Disorders: Listening to the Gene
Neuroscientist, 1998, 4, 25-34
4.726Citations (PDF)
524Knockout mice in neuropsychopharmacology: present and future2.06Citations (PDF)
525Genes for personality traits: implications for psychopathology2.037Citations (PDF)
526Altered Brain Serotonin Homeostasis and Locomotor Insensitivity to 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Serotonin Transporter-Deficient Mice
Molecular Pharmacology, 1998, 53, 649-655
2.8619Citations (PDF)
527The appetite suppressant d-fenfluramine induces apoptosis in human serotonergic cells
NeuroReport, 1998, 9, 2989-2993
1.520Citations (PDF)
528In Vivo Association Between Alcohol Intoxication, Aggression, and Serotonin Transporter Availability in Nonhuman Primates
American Journal of Psychiatry, 1998, 155, 1023-1028
10.5161Citations (PDF)
529Short CAG repeats within the hSKCa3 gene associated with schizophrenia
NeuroReport, 1998, 9, 3595-3599
1.534Citations (PDF)
530Cocaine reward models: Conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice7.7421Citations (PDF)
531Functional Characterization of the Murine Serotonin Transporter Gene Promoter in Serotonergic Raphe Neurons
Journal of Neurochemistry, 1998, 70, 932-939
4.036Citations (PDF)
532Serotonin transporter (5-HTT) gene variants associated with autism?
Human Molecular Genetics, 1997, 6, 2233-2238
3.1216Citations (PDF)
533Functional promoter polymorphism of the human serotonin transporter
Psychiatric Genetics, 1997, 7, 45-48
1.4111Citations (PDF)
534Das maligne neuroleptische Syndrom und die akute lebensbedrohliche Katatonie - zwei gegensätzliche Krankheitsentitäten?0.43Citations (PDF)
535Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimerʼs disease
NeuroReport, 1997, 8, 683-686
1.592Citations (PDF)
536Serotonin transporter gene-linked polymorphic region: Allele distributions in relationship to body weight and in anorexia nervosa
Life Sciences, 1997, 61, PL295-PL303
4.591Citations (PDF)
537Gene structure and 5′-flanking regulatory region of the murine serotonin transporter
Molecular Brain Research, 1997, 44, 286-292
2.847Citations (PDF)
538Association Analysis of a Regulatory Variation of the Serotonin Transporter Gene with Severe Alcohol Dependence2.7134Citations (PDF)
539Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene
Molecular Psychiatry, 1997, 2, 403-406
8.3135Citations (PDF)
540Cellular localization and expression of the serotonin transporter in mouse brain
Brain Research, 1997, 778, 338-345
2.555Citations (PDF)
541Koinzidenz von Chorea Huntington und Epilepsie
Der Nervenarzt, 1997, 68, 270-273
0.94Citations (PDF)
542The human serotonin transporter gene polymorphism-basic research and clinical implications
Journal of Neural Transmission, 1997, 104, 1005-1014
3.6181Citations (PDF)
543Molecular heterogeneity of neurotransporters: implications for neurodegeneration
1997, , 155-167
1Citations (PDF)
544Human Olfactory Neuroepithelial Cells: Tyrosine Phosphorylation and Process Extension Are Increased by the Combination of IL-1β, IL-6, NGF, and bFGF
Experimental Neurology, 1996, 142, 179-194
4.132Citations (PDF)
545The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes3.635Citations (PDF)
546Serotonin transporter gene polymorphism and affective disorder
Lancet, The, 1996, 347, 1340-1341
35.389Citations (PDF)
547Identification of serotonin transporter mRNA in rat platelets
Journal of Neural Transmission, 1996, 103, 957-965
3.616Citations (PDF)
548Systematic screening for mutations in the coding region of the human serotonin transporter (5-HTT) gene using PCR and DGGE
1996, 67, 541-545
49Citations (PDF)
549Der 5-HT<sub>1A</sub>-Rezeptor: Ein neues Wirkprinzip psychopharmakologischer Therapiestrategien?0.49Citations (PDF)
550Periodic catatonia: A schizophrenic subtype with major gene effect and anticipation2.979Citations (PDF)
551Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects
Psychopharmacology, 1995, 120, 356-364
3.039Citations (PDF)
552Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene
Journal of Neural Transmission, 1995, 102, 247-254
3.6236Citations (PDF)
553Primary structure of the serotonin transporter in unipolar depression and bipolar disorder
Biological Psychiatry, 1995, 37, 215-223
1.7108Citations (PDF)
554Organization of the human serotonin transporter gene3.6507Citations (PDF)
555Triplet repeats in clinical subtypes of schizophrenia: variation at the DRPLA (B37 CAG repeat) locus is not associated with periodic catatonia3.621Citations (PDF)
556Protein alterations in olfactory neuroblasts from Alzheimer donors
Neurobiology of Aging, 1994, 15, 675-680
3.48Citations (PDF)
557Direct sequencing of the reserpine-sensitive vesicular monoamine transporter complementary DNA in unipolar depression and manic depressive illness
Psychiatric Genetics, 1994, 4, 153-160
1.413Citations (PDF)
558Primary Structure of the Human Platelet Serotonin Uptake Site: Identity with the Brain Serotonin Transporter
Journal of Neurochemistry, 1993, 60, 2319-2322
4.0479Citations (PDF)
559Isolation of a cDNA encoding the human brain serotonin transporter3.6191Citations (PDF)
560Extensive sequence divergence between the human and rat brain vesicular monoamine transporter: Possible molecular basis for species differences in the susceptibility to MPP+3.619Citations (PDF)
561Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants
Molecular Brain Research, 1993, 17, 31-35
2.8191Citations (PDF)
562Periodic maximum range cruise with singular control3.915Citations (PDF)
563Signal-transducing G proteins and antidepressant Drugs: Evidence for modulation of α subunit gene expression in rat brain
Biological Psychiatry, 1992, 32, 549-579
1.774Citations (PDF)
564Fluoxetine modulates G protein αs, αq and α12 subunit mRNA expression in rat brain2.326Citations (PDF)
5653-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid decreases NMDA receptor mRNA2.312Citations (PDF)
5665-HT1A receptor-effector system responsivity in panic disorder
Psychopharmacology, 1992, 106, 111-117
3.092Citations (PDF)
5675-HT1A receptor responsivity in anxiety disorders and depression4.1116Citations (PDF)
568The 5-HT receptor ? G-protein ? effector system complex in depression I. Effect of glucocorticoids3.648Citations (PDF)
569Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder
Psychopharmacology, 1991, 105, 415-420
3.087Citations (PDF)
570Psychobiologie der Zwangskrankheit0.48Citations (PDF)
5715-Hydroxytryptamine1A (5-HT1A) Receptor Responsivity in Anxiety Disorders and Depression
1991, , 130-144
1Citations (PDF)
572Zur Serotonin-Hypothese der Depression*0.4109Citations (PDF)
573Pharmacology of the hypothermic response to 5-HT1A receptor activation in humans2.293Citations (PDF)
574The influence of dexamethasone on growth hormone (GH). Response to GH-releasing hormone in normal men3.62Citations (PDF)
5755-HT1A receptor function in depression: effect of chronic amitriptyline treatment3.666Citations (PDF)
576Corticotropin and Cortisol Secretion after Central 5-Hydroxytryptamine-1A (5-HT1A) Receptor Activation: Effects of 5-HT Receptor andβ-Adrenoceptor Antagonists4.4104Citations (PDF)
5775-HT1A receptor responsivity in unipolar depression Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls
Biological Psychiatry, 1990, 28, 620-628
1.7156Citations (PDF)
578Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression
Life Sciences, 1990, 46, 1271-1277
4.592Citations (PDF)
579Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder
1990, , 189-195
4Citations (PDF)
580The influence of human corticotropin-releasing hormone on somatostatin secretion in depressed patients and controls3.69Citations (PDF)
581Psychoneuroendocrine research in depression3.622Citations (PDF)
582Psychoneuroendocrine research in depression3.622Citations (PDF)
583Effects of glucocorticoids on the regulation of the hypothalamic-pituitary-somatotropic system in depression4.718Citations (PDF)
584Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans
Biological Psychiatry, 1989, 26, 203-205
1.780Citations (PDF)
585Comparison of GH responses after human GHRH-44 amide administration and TRH-induced TSH release in depressed patients
Biological Psychiatry, 1989, 25, 235-238
1.710Citations (PDF)
586Blunted Adrenocorticotropin but Normal β-Endorphin Release after Human Corticotropin-Releasing Hormone Administration in Depression4.457Citations (PDF)
587Growth hormone (GH) responses to GH-releasing hormone in depression: Correlation with GH release following clonidine
Psychiatry Research, 1988, 25, 301-310
3.430Citations (PDF)
588Corticotropin and Cortisol Response to Human CRH as a probe for HPA system integrity in major depressive disorder
Psychiatry Research, 1988, 24, 25-34
3.456Citations (PDF)
589Delta sleep-inducing peptide response to human corticotropin-releasing hormone (CRH) in major depressive disorder
Biological Psychiatry, 1988, 24, 162-172
1.714Citations (PDF)
590Abnormal responsiveness of growth hormone to human corticotropin-releasing hormone in major depressive disorder4.713Citations (PDF)
591Growth hormone (GH) and prolactin responses after GH-releasing hormone in major depressive disorder: Relationship to somatomedin C levels and dexamethasone suppressibility of cortisol
Psychoneuroendocrinology, 1988, 13, 255-263
2.514Citations (PDF)
592Pre- and Postsynaptic Alpha-Adrenergic Effects of Clonidine in Major Depressive Disorder
Pharmacopsychiatry, 1988, 21, 430-431
3.38Citations (PDF)
593Clinical and Biochemical Effects of the Selective Phosphodiesterase Inhibitor Rolipram in Depressed Inpatients Controlled by Determination of Plasma Level
Pharmacopsychiatry, 1988, 21, 378-379
3.312Citations (PDF)
594Alpha-Adrenoceptor Function in Acute Paranoid Schizophrenia
Pharmacopsychiatry, 1988, 21, 402-403
3.31Citations (PDF)
595Neuroendocrine Regulation of Growth Hormone Secretion in Major Depressive Disorder
Pharmacopsychiatry, 1988, 21, 440-442
3.32Citations (PDF)
596Growth Hormone (GH) Response to GH-Releasing Hormone in Depression4.450Citations (PDF)
597Androgen receptor binding activity in meningiomas
World Neurosurgery, 1987, 28, 176-180
0.715Citations (PDF)
598Estrophilin immunoreactivity versus estrogen receptor binding activity in meningiomas: Evidence for multiple estrogen binding sites
World Neurosurgery, 1987, 28, 181-188
0.75Citations (PDF)
599Attenuated growth hormone response to growth hormone-releasing hormone in major depressive disorder
Biological Psychiatry, 1987, 22, 1495-1499
1.721Citations (PDF)
600Gonadal steroid receptors in meningiomas
Journal of Neurology, 1987, 234, 328-333
3.421Citations (PDF)
601Simultaneous estradiol and progesterone receptor analysis in meningiomas
World Neurosurgery, 1986, 26, 257-263
0.726Citations (PDF)
602Neurogenetics of Personality Disorders
0, , 1387-1412
0Citations (PDF)